Applied DNA Sciences Inc (APDN)
4.02
+0.02
(+0.50%)
USD |
NASDAQ |
May 01, 16:00
4.16
+0.14
(+3.48%)
After-Hours: 20:00
Applied DNA Sciences Enterprise Value: 0.0063M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 0.0063M |
| April 30, 2024 | -0.011M |
| April 29, 2024 | -0.1404M |
| April 26, 2024 | 0.3083M |
| April 25, 2024 | 0.852M |
| April 24, 2024 | 0.6587M |
| April 23, 2024 | 1.542M |
| April 22, 2024 | 2.233M |
| April 19, 2024 | 2.362M |
| April 18, 2024 | 2.269M |
| April 17, 2024 | 2.191M |
| April 16, 2024 | 2.383M |
| April 15, 2024 | 2.652M |
| April 12, 2024 | 2.968M |
| April 11, 2024 | 3.006M |
| April 10, 2024 | 3.230M |
| April 09, 2024 | 3.199M |
| April 08, 2024 | 3.269M |
| April 05, 2024 | 3.160M |
| April 04, 2024 | 3.330M |
| April 03, 2024 | 4.041M |
| April 02, 2024 | 3.821M |
| April 01, 2024 | 3.668M |
| March 28, 2024 | 3.498M |
| March 27, 2024 | 3.804M |
| Date | Value |
|---|---|
| March 26, 2024 | 3.934M |
| March 25, 2024 | 4.686M |
| March 22, 2024 | 5.009M |
| March 21, 2024 | 5.026M |
| March 20, 2024 | 5.026M |
| March 19, 2024 | 4.118M |
| March 18, 2024 | 4.007M |
| March 15, 2024 | 2.785M |
| March 14, 2024 | 2.853M |
| March 13, 2024 | 4.748M |
| March 12, 2024 | 5.535M |
| March 11, 2024 | 5.535M |
| March 08, 2024 | 5.773M |
| March 07, 2024 | 6.045M |
| March 06, 2024 | 6.079M |
| March 05, 2024 | 6.214M |
| March 04, 2024 | 5.909M |
| March 01, 2024 | 6.045M |
| February 29, 2024 | 6.406M |
| February 28, 2024 | 6.656M |
| February 27, 2024 | 6.588M |
| February 26, 2024 | 7.029M |
| February 23, 2024 | 7.573M |
| February 22, 2024 | 7.700M |
| February 21, 2024 | 7.912M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-0.7612M
Minimum
Oct 03 2022
90.55M
Maximum
Feb 11 2021
19.78M
Average
14.71M
Median
Jul 19 2019
Enterprise Value Benchmarks
| Fonar Corp | 42.65M |
| XWELL Inc | -7.927M |
| ProPhase Labs Inc | 98.64M |
| Veracyte Inc | 1.295B |
| OncoCyte Corp | 24.85M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.105M |
| Revenue (Quarterly) | 0.8912M |
| Total Expenses (Quarterly) | 4.680M |
| EPS Diluted (Quarterly) | -1.80 |
| Gross Profit Margin (Quarterly) | 25.93% |
| Profit Margin (Quarterly) | -124.0% |
| Earnings Yield | -273.6% |
| Normalized Earnings Yield | -503.26 |